RedHill Biopharma Ltd.RDHLNASDAQ
Loading
Revenue Growth Recovery in ProgressRecovering
Percentile Rank57
3Y CAGR-11.3%
Year-over-Year Change
Year-over-year revenue growth rate
3Y CAGR
-11.3%/yr
vs -69.5%/yr prior
Acceleration
+58.2pp
Accelerating
Percentile
P57
Within normal range
vs 3Y Ago
0.7x
Contraction
Streak
1 yr
Consecutive growthRecovering
| Period | Value |
|---|---|
| 2024 | 23.17% |
| 2023 | -89.43% |
| 2022 | -27.94% |
| 2021 | 33.25% |
| 2020 | 923.03% |
| 2019 | -24.75% |
| 2018 | 108.63% |
| 2017 | 3867.33% |
| 2016 | 3266.67% |
| 2015 | -99.96% |